D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
2076
DELISTED
Premier
PINC
| $3.13M | ﹤0.01% |
92,308
+9,718
| +12% | +$337K |
|
|
SIVB
2077
DELISTED
SVB Financial Group
SIVB
| $3.12M | ﹤0.01% |
6,324
+2,649
| +72% | +$1.3M |
|
2078
PUT
McCormick & Company Non-Voting
MKC
$13.9B
| $3.12M | ﹤0.01% |
35,000
-3,200
| -8% | -$285K |
|
2079
PUT
Shake Shack
SHAK
$2.55B
| $3.11M | ﹤0.01% |
27,600
-88,100
| -76% | -$10.1M |
|
2080
argenx
ARGX
$54.6B
| $3.1M | ﹤0.01% |
+11,257
| New | +$3.56M |
|
|
LJPC
2081
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $3.1M | ﹤0.01% |
731,137
+315,401
| +76% | +$1.74M |
|
2082
CALL
Cinemark Holdings
CNK
$4.09B
| $3.1M | ﹤0.01% |
+151,800
| New | +$3.2M |
|
2083
PUT
Take-Two Interactive
TTWO
$46.3B
| $3.09M | ﹤0.01% |
17,500
+14,000
| +400% | +$2.65M |
|
|
HTB
2084
HomeTrust Bancshares
HTB
$856M
| $3.09M | ﹤0.01% |
126,827
-18,586
| -13% | -$421K |
|
|
GRMN
2085
CALL
Garmin
GRMN
$48.9B
| $3.08M | ﹤0.01% |
23,400
-21,300
| -48% | -$2.65M |
|
|
SPNS
2086
DELISTED
Sapiens International
SPNS
| $3.08M | ﹤0.01% |
97,038
-5,836
| -6% | -$189K |
|
2087
Teekay
TK
$981M
| $3.08M | ﹤0.01% |
963,458
+403,527
| +72% | +$1.24M |
|
2088
Protolabs
PRLB
$1.78B
| $3.08M | ﹤0.01% |
+25,269
| New | +$4.2M |
|
2089
Flowers Foods
FLO
$1.6B
| $3.07M | ﹤0.01% |
128,931
-123,070
| -49% | -$2.81M |
|
2090
Gates Industrial Corporation Ltd.
GTES
$6.69B
| $3.04M | ﹤0.01% |
190,354
+144,197
| +312% | +$2.23M |
|
2091
PUT
Teradyne
TER
$50.2B
| $3.04M | ﹤0.01% |
25,000
| – | – |
|
2092
Primoris Services
PRIM
$4.28B
| $3.03M | ﹤0.01% |
91,538
-64,839
| -41% | -$2.13M |
|
2093
Materion
MTRN
$4.36B
| $3.03M | ﹤0.01% |
45,779
+17,390
| +61% | +$1.21M |
|
|
SPKBU
2094
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
| $3.03M | ﹤0.01% |
+304,855
| New | +$3.04M |
|
2095
Ardelyx
ARDX
$1.26B
| $3.03M | ﹤0.01% |
457,489
-390,775
| -46% | -$2.68M |
|
2096
CALL
Kinder Morgan
KMI
$70.3B
| $3.03M | ﹤0.01% |
181,800
+107,100
| +143% | +$1.64M |
|
2097
Ingles Markets
IMKTA
$1.71B
| $3.02M | ﹤0.01% |
49,060
-9,378
| -16% | -$491K |
|
2098
PUT
Consolidated Edison
ED
$41.3B
| $3.01M | ﹤0.01% |
40,200
+2,000
| +5% | +$141K |
|
|
FLOW
2099
DELISTED
SPX FLOW, Inc.
FLOW
| $3.01M | ﹤0.01% |
47,460
-9,671
| -17% | -$585K |
|
2100
Pliant Therapeutics
PLRX
$66.3M
| $3M | ﹤0.01% |
+76,347
| New | +$2.48M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.